GLASGOW 2018

Learn more

OUR MEDICINES

LEARN MORE

In the management of HIV, times are changing

Are your treatment decisions for your virologically suppressed patients changing with them?

LEARN MORE ABOUT 2DR

The first single-pill, 2-drug regimen for your virologically suppressed patients.

LEARN MORE

Latest Videos

Our medicines

JULUCA

JULUCA (dolutegravir/rilpivirine) is indicated for HIV-1 virologically suppressed adults on a stable regimen for at least 6 months with no history of virological failure and no known or suspected resistance to any NNRTI or INI.

 

TIVICAY

Tivicay (dolutegravir) is indicated in combination with other anti-retroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults, adolescents and children above 6 years of age.

UK/DTGP/0002/17(8) | November 2018